GL1X · GenesisL1 explorer

MolNFT v1 · #105862 · protein

Crystal structure of human COQ9 in complex with a phospholipid, northeast structural genomics consortium target HR5043

4RHP · Ubiquinone biosynthesis protein COQ9, mitochondrial: “Crystal structure of human COQ9 in complex with a phospholipid, northeast structural genomics consortium…”. X-ray diffraction, 1 ligand (PEF), 2 pockets (best druggability 0.86).…

PDB
4RHP
Type
protein
Length
396 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ubiquinone biosynthesis protein COQ9, mitochondrial
UniProt
O75208
Ligands
PEF
Pockets
2 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 76% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUbiquinone biosynthesis protein COQ9, mitochondrialprotein18977% helix, 0% strandO75208
BUbiquinone biosynthesis protein COQ9, mitochondrialprotein20775% helix, 0% strandO75208

Ligands and binding sites

  • PEF · Di-palmitoyl-3-sn-phosphatidylethanolamine · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17970.860.8867PEF
2500.360.7912empty

Interfaces

1 interface between chains.

  • A–B · 1306 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 21 modified (engineered).

Compared structures

  • 4RHP · Crystal structure of human COQ9 in complex with a phospholipid, Northeast Structural… · the same entry in another collection · chain A against A, TM-score 1.00
  • O75208 · AlphaFold monomer V2.0 prediction for ubiquinone biosynthesis protein COQ9, mitochondrial… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.